The pharmaceutical world is witnessing a remarkable shift in blood sugar treatment with the emergence of GLP-1 transdermal devices. These patches offer a possibly more user-friendly alternative to shots of GLP-1 medications, minimizing the frequency of daily needle pricks. The technology releases the medication directly through the surface, arguabl